Financhill
Sell
45

MRSN Quote, Financials, Valuation and Earnings

Last price:
$0.31
Seasonality move :
-7.32%
Day range:
$0.35 - $0.38
52-week range:
$0.26 - $2.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.15x
P/B ratio:
57.95x
Volume:
3M
Avg. volume:
2.4M
1-year change:
-85.44%
Market cap:
$47.4M
Revenue:
$40.5M
EPS (TTM):
-$0.56

Earnings Data

Next earnings date for MRSN
May 15
2025
Most recent earnings per share
-$0.11
Beat by $0.06
(Mar 3/2025)
Consensus Estimate
-$0.17
(Mar 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRSN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $6.1M -- -- -$0.20 --
05/15/2025 Q1 $6M -- -- -$0.19 --
03/03/2025 Q4 $7.7M $16.4M -$0.11 -$0.17 $0.06
11/13/2024 Q3 $7.6M $12.6M -$0.09 -$0.19 $0.10
08/13/2024 Q2 $8.7M $2.3M -$0.20 -$0.18 -$0.02
05/09/2024 Q1 $8.3M $9.2M -$0.16 -$0.18 $0.02
02/28/2024 Q4 $14.8M $10.7M -$0.16 -$0.19 $0.03
11/07/2023 Q3 -- -- -$0.35 -$0.34 -$0.01
08/08/2023 Q2 -- -- -$0.47 -$0.48 $0.01
05/09/2023 Q1 -- -- -$0.52 -$0.48 -$0.04
02/28/2023 Q4 -- -- -$0.44 -$0.52 $0.08
11/07/2022 Q3 -- -- -$0.61 $0.06 -$0.67
08/08/2022 Q2 -- -- -$0.55 -$0.50 -$0.05
05/09/2022 Q1 -- -- -$0.59 -$0.27 -$0.32
02/28/2022 Q4 -- -- -$0.68 -$0.65 -$0.03
11/09/2021 Q3 -- -- -$0.63 -$0.57 -$0.06
08/06/2021 Q2 -- -- -$0.59 -$0.49 -$0.10
05/10/2021 Q1 -- -- -$0.50 -$0.38 -$0.12
02/26/2021 Q4 -- -- -$0.43 -$0.32 -$0.11
11/09/2020 Q3 -- -- -$0.33 -$0.30 -$0.03
08/07/2020 Q2 -- -- -$0.33 -$0.29 -$0.04
05/08/2020 Q1 -- -- -$0.35 -$0.37 $0.02
02/28/2020 Q4 -- -- -$0.34 -$0.38 $0.04
11/06/2019 Q3 -- -- -$0.35 -$0.37 $0.02
08/08/2019 Q2 -- -- -$0.36 -$0.39 $0.03
05/09/2019 Q1 -- -- $0.70 -$0.07 $0.77
03/08/2019 Q4 -- -- -$0.97 -$0.68 -$0.29
11/13/2018 Q3 -- -- -$0.75 -$0.59 -$0.16
08/15/2018 Q2 -- -- -$0.54 -$0.58 $0.04
05/14/2018 Q1 -- -- -$0.54 -$0.59 $0.05
03/28/2018 Q4 -- -- -$0.61 -$0.48 -$0.13
11/09/2017 Q3 -- -- -$0.35 -$0.43 $0.08
08/11/2017 Q2 -- -- -$0.39 -$0.54 $0.15

Mersana Therapeutics Earnings Questions

  • How Much did Mersana Therapeutics Generate in Revenue Last Quarter?

    Mersana Therapeutics reported $16.4M worth of top line sales in its most recent quarter.

  • Did Mersana Therapeutics Beat Earnings Last Quarter?

    Mersana Therapeutics announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.17 per share.

  • Is Mersana Therapeutics Profitable?

    Mersana Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Mersana Therapeutics EPS Next Year?

    Mersana Therapeutics's earnings are forecast to decrease from -$0.56 per share to -$0.61 per share next year representing a decrease of -36.79%.

  • When is Mersana Therapeutics's Earnings Date?

    Currently, Mersana Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 9.76% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 3.67% over the past day.

Sell
29
GLBE alert for May 15

Global E Online [GLBE] is down 3.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock